SCHEMBL6710174

SCHEMBL6710174

O=C(Nc1ccc(Br)cc1-c1nnn[nH]1)c1noc2cc(O)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 6/20 0.36
ESR1 P03372 2/20 0.36
HSP90AA1 P07900 2/20 0.36
ESR2 Q92731 2/20 0.36
GPR35 Q9HC97 5/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 2/20 0.35
AKR1C4 P17516 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
SNCA P37840 1/20 0.34
LMNA P02545 2/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712127 0.90 HIF1A (0.35) HIF1AGPR35MEN1KMT2AHPGD
SCHEMBL6711782 0.90 HIF1A (0.41) HIF1AGPR35MEN1KMT2AHPGD
SCHEMBL6707842 0.89 HIF1A (0.43) HIF1AESR1HSP90AA1ESR2MEN1
SCHEMBL6708059 0.89 HIF1A (0.49) HIF1A
SCHEMBL6710349 0.89 HIF1A (0.38) HIF1AGPR35MEN1KMT2AHPGD
SCHEMBL6710496 0.88 GPR35 (0.46) HIF1AGPR35MEN1KMT2AHPGD
SCHEMBL6710038 0.88 HIF1A (0.45) HIF1AGPR35MEN1KMT2ANPSR1
SCHEMBL6710167 0.87 ESR1 (0.38) HIF1AESR1HSP90AA1ESR2LMNA
SCHEMBL6713264 0.86 GPR35 (0.39) HIF1AGPR35MEN1KMT2AHPGD
SCHEMBL6709988 0.86 TNIK (0.35) HIF1AGPR35NPSR1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885ESR1 237/4885HSP90AA1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.